Mao Li
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Single-minded homolog 2 as a potential prognostic signature and assessment of its correlation with immune cell infiltration in pancreatic cancer.
Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists
Published: January 01, 2023
LncRNA GAS8-AS1 is a Novel Prognostic and Diagnostic Biomarker for Pancreatic Cancer.
Journal: Critical reviews in eukaryotic gene expression
Published: June 13, 2022
Comment on: Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis.
Journal: The British journal of surgery
Published: February 01, 2022
Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review).
Journal: International journal of oncology
Published: August 03, 2021
Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis.
Journal: Clinical and experimental medicine
Published: August 03, 2021
An Unexpected Case Report of Adrenal Lymphangioma: Mimicking Metastatic Tumor on Imaging in a Patient With Pancreatic Cancer.
Journal: Frontiers in endocrinology
Published: September 29, 2020
MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy.
Journal: Bioscience reports
Published: August 09, 2018
Downregulation of LINC01638 lncRNA inhibits migration and invasion of pancreatic ductal adenocarcinoma cells by reducing TGF‑β signaling.
Journal: Molecular medicine reports
Published: July 28, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026